Maxbon

Ibandronic acid
Bisphosphonate Preparations (Antiosteoporotic Preparations)

Indication:
Maxbon™ Tablet is indicated for:

  • Treatment and prevention of postmenopausal osteoporosis in women
  • Treatment and prevention of osteoporosis in men

Dosage & Administration:
The recommended dose for the treatment and prevention of osteoporosis is 150 mg tablet once in a month and on the same date of each month is recommended.

Preparation:
Maxbon™ Tablet: Each box contains 1 film coated tablet in Alu-Alu blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides